Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.

Summary: Chronic nerve pain, or neuropathic pain, is notoriously difficult to treat. When standard first-line medications fail, patients are often switched to second-line options like pregabalin, lidocaine plasters, or duloxetine to manage their suffering and improve quality of life. However, a recent review of medical literature reveals a surprising gap in our knowledge. Researchers found only 17 relevant studies—most of which were small and of variable quality—and discovered no direct comparisons between these drugs for difficult-to-treat cases. While pregabalin showed some benefits for sleep and distress, there is very little high-quality evidence guiding doctors on which of these treatments is best for patients who haven't found relief elsewhere. The medical community urgently needs better, "gold-standard" trials to solve this puzzle.